Continuing the theme of RSV, for the third consecutive year, the ISIRV Epidemiology Group (ISIRVEpi) and the ESCMID Study Group for Respiratory Viruses (ESGREV) joined forces to deliver a high-profile educational session at ESCMID Global 2025 in Vienna, Austria. This ongoing collaboration between ESGREV and ISIRV continues to foster scientific exchange and visibility.
This year’s session, titled “RSV Infections: diagnosis, surveillance and treatment in the advent of vaccines” took place on Saturday 12 April 2025. The session was accredited for CME and was designed to bring together leading voices in RSV research and clinical care to help update a broad European audience. For more information, please refer to the ESCMID Global 2025 program.
